These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 4040847

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    Trübestein G, von Bary S, Breddin K, Diehm C, Gruss JD, Heinrich H, Horsch S, Kriessmann A, Maass U, Martin M.
    Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L, Vranes M, Cernak I, Kostić D, Lovrić A, Sagić D, Lotina S.
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A, Caspary L, Alexander K.
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann M, Ranft J.
    Vasa; 1991; 20(1):13-6. PubMed ID: 2031393
    [Abstract] [Full Text] [Related]

  • 35. [Intravenous PGE-1 in peripheral vascular obstructive disease: use over a 6-month period].
    Llorente Gutiérrez J, González Fernández MA, Fuentes Irigoyen R, Jiménez Caballero E.
    Farm Hosp; 2004; 28(3):188-91. PubMed ID: 15222872
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
    Peskar BA, Cawello W, Rogatti W, Rudofsky G.
    J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.